Human Hair Loss

• • NOTOC**

Human Hair Loss

Human hair loss, or alopecia, encompasses a diverse group of conditions ranging from temporary increases in hair shedding to progressive destruction of hair follicles. Hair loss may be hereditary, hormonal, autoimmune, inflammatory, infectious, nutritional, medication-induced, mechanically induced, or related to major physiological stresses such as illness, surgery, rapid weight loss, or chemotherapy.

The biological and clinical distinction between excessive hair shedding and progressive hair loss is important. Some disorders temporarily alter the normal hair-growth cycle while leaving follicles capable of producing new hair. Other conditions progressively miniaturize follicles, and scarring alopecias can permanently destroy them.

Hair loss is therefore not a single disease. Accurate diagnosis depends on the pattern and timing of hair loss, accompanying scalp changes, medical history, medications, nutritional status, hormonal factors, family history, and specialized examination when necessary.

Hair Follicle Biology and the Hair Cycle

Human hair follicles repeatedly pass through stages of growth and rest. The major phases are anagen, the active growth phase; catagen, a transitional phase; and telogen, the resting phase that precedes shedding.

Disruption of this cycle can produce several forms of alopecia. An increased number of follicles entering telogen can cause diffuse shedding known as telogen effluvium. Damage to rapidly dividing cells in growing follicles can produce anagen effluvium. In androgenetic alopecia, susceptible follicles progressively miniaturize and produce thinner and shorter hairs.

Hair follicles also contain complex stem-cell niches and interact with dermal papilla cells, hormones, immune cells, signaling molecules, blood vessels, and microorganisms. Research into these systems has increasingly connected hair loss with genetics, inflammation, aging, immune regulation, and regenerative biology.

Diagnosis of Hair Loss

Diagnosis generally begins with medical history and examination of the scalp and hair. Important questions include whether the loss is sudden or gradual, diffuse or localized, whether excessive shedding is occurring, and whether itching, pain, inflammation, scaling, pustules, or scarring are present.

A clinician may use a hair-pull test, examine hair shafts and follicular openings, and order laboratory studies when nutritional deficiencies, thyroid disease, hormonal abnormalities, autoimmune disease, or other systemic causes are suspected.

Trichoscopy uses magnified visualization of the scalp and follicles. Features such as variation in hair diameter, vellus hairs, yellow dots, black dots, broken hairs, hair casts, loss of follicular openings, and characteristic vascular or pigmentation patterns can help differentiate androgenetic alopecia, alopecia areata, telogen effluvium, traction alopecia, fungal infection, and scarring disorders.

A scalp biopsy may be needed when the diagnosis remains uncertain or when scarring alopecia is suspected. Histopathology can help determine whether follicles are being miniaturized, inflamed, damaged, or permanently destroyed.

Androgenetic Alopecia

Androgenetic alopecia is one of the most extensively studied forms of hair loss. It includes male-pattern hair loss and much of what is described as female-pattern hair loss.

The disorder has a substantial genetic component. Large genetic studies have identified numerous susceptibility loci involving androgen signaling, follicular development, WNT signaling, extracellular-matrix biology, and other pathways. In genetically susceptible follicles, androgen-related signaling contributes to progressive miniaturization, causing terminal hairs to become shorter, finer, and eventually difficult to see.

Men commonly develop recession around the temples and thinning over the crown. Women more often develop diffuse thinning over the central or upper scalp while retaining more of the frontal hairline, although patterns vary considerably.

Female-pattern hair loss becomes more common with age and has been studied in relation to menopause, hormones, and polycystic ovary syndrome. Hyperandrogenism and metabolic abnormalities may contribute in some women but do not explain all cases.

Established and commonly studied treatments include topical minoxidil and, in appropriate patients, medications that modify androgen activity. Research also examines low-dose oral minoxidil, finasteride, dutasteride, platelet-rich plasma, low-level laser or light therapy, microneedling and other procedural approaches.

Hair transplantation can redistribute genetically resistant follicles into areas affected by stable pattern hair loss. Modern approaches include follicular-unit transplantation and follicular-unit extraction.

Alopecia Areata

Alopecia areata is an immune-mediated disorder in which immune activity targets growing hair follicles. It can produce one or more sharply defined patches of hair loss, but disease severity ranges from limited patches to loss of nearly all scalp hair, known as alopecia totalis, or much of the body's hair, known as alopecia universalis.

Research indicates that collapse of the hair follicle's normal immune privilege is central to the disease. Cytotoxic immune cells and inflammatory signaling pathways, including the JAK-STAT system, can attack growing follicles. Genetics contributes to susceptibility, and many immune-regulatory genes associated with alopecia areata overlap with pathways involved in other autoimmune disorders.

Alopecia areata has associations with thyroid disease, atopic disease, other autoimmune conditions, metabolic abnormalities and psychiatric or psychological burdens in some populations.

Treatment varies according to age, severity and extent of disease. Corticosteroids may be applied topically or injected into affected areas. Contact immunotherapy and systemic therapies are used in selected cases.

JAK inhibitors have significantly expanded research and therapeutic options for moderate-to-severe disease. Clinical trials and meta-analyses have found substantial hair regrowth in some patients receiving systemic JAK-directed treatment, although effectiveness, adverse effects and relapse after stopping therapy remain important considerations.

By 2026, U.S. expert consensus recommendations had been developed to improve treatment consistency for adults with severe alopecia areata. Other immune pathways are also under investigation, including experimental therapies aimed at inflammatory signals beyond the JAK pathway.

Telogen Effluvium and Diffuse Hair Shedding

Telogen effluvium occurs when an unusually large number of follicles enter the resting stage and subsequently shed. It usually presents as diffuse thinning rather than sharply localized bald patches.

Recognized triggers include:

• major illness
• fever or infection
• surgery
• emotional or physiological stress
• rapid weight loss
• childbirth
• medications
• endocrine abnormalities
• inadequate nutrition
• iron or other micronutrient deficiencies

COVID-19 was followed in many patients by delayed telogen effluvium, contributing to renewed study of post-infectious hair shedding. Hair loss after bariatric surgery has similarly been associated with surgical stress, rapid weight loss, reduced protein intake, and deficiencies involving iron, zinc, folate and other nutrients.

Treatment generally focuses on identifying and addressing the initiating cause. Because the follicle itself often remains viable, regrowth may occur after the triggering disturbance resolves.

Anagen effluvium differs from telogen effluvium because actively growing hairs are injured. Chemotherapy, radiation and certain toxic exposures can disrupt rapidly dividing follicular cells and cause abrupt hair loss.

Nutrition, Medications and Systemic Disease

Hair growth depends on normal cellular metabolism, but the relationship between supplements and hair loss is often more complicated than commercial claims suggest.

Research has examined iron, vitamin D, zinc, B vitamins, selenium, copper and other micronutrients. Iron deficiency has been associated with some forms of diffuse nonscarring hair loss, while vitamin D abnormalities have been reported in several alopecia populations. However, observational associations do not mean that supplementation will restore hair in every patient.

Evidence supporting routine biotin supplementation for people without a documented deficiency is limited.

Medications can also produce hair loss through several mechanisms, including telogen effluvium, anagen effluvium and occasionally immune-mediated reactions. Determining whether a medication is responsible requires consideration of timing, dose, other possible causes and the underlying medical condition.

Traction, Infection and Other Acquired Causes

Traction alopecia results from repeated mechanical tension on hair follicles. Tight braids, extensions, ponytails, weaves and other hairstyles that repeatedly pull on the hair can produce thinning and breakage.

Early traction alopecia may improve when damaging practices are stopped. Continued tension can eventually cause inflammation, follicular damage and permanent scarring. Prevention is therefore especially important.

Scalp fungal infection, particularly tinea capitis, can also cause patchy hair loss. Clinical forms include gray-patch and black-dot alopecia and inflammatory kerion. Appropriate diagnosis and systemic antifungal treatment are important.

Hair loss can occasionally occur as a manifestation of systemic infection or other disease. Secondary syphilis, for example, can produce distinctive moth-eaten or diffuse alopecia that may resolve when the infection is treated.

Scarring Alopecia

Scarring alopecia, also called cicatricial alopecia, refers to disorders in which inflammation ultimately destroys the follicle and replaces it with scar tissue. Unlike many nonscarring alopecias, advanced follicular destruction is irreversible.

Major forms discussed in the research include:

• central centrifugal cicatricial alopecia
• lichen planopilaris
• frontal fibrosing alopecia
• folliculitis decalvans
• dissecting cellulitis of the scalp
• lupus-associated cicatricial alopecia

Central centrifugal cicatricial alopecia often begins near the central scalp and can progressively expand. Research has moved beyond earlier explanations focused primarily on hot-comb use and now examines genetic susceptibility, follicular structure, inflammation and hairstyling practices.

Frontal fibrosing alopecia produces progressive scarring hair loss, commonly along the frontal and temporal scalp, and may also involve eyebrows or facial and body hair. It is related pathologically to lichen planopilaris.

Because destroyed follicles cannot readily be regenerated with current established therapies, early recognition of inflammatory scarring alopecia is particularly important. Treatment generally aims to suppress inflammatory activity and prevent additional permanent loss rather than simply stimulate growth.

Chemotherapy-Induced Hair Loss

Chemotherapy frequently damages rapidly dividing cells in active follicles, causing anagen effluvium. The extent of hair loss depends on the drug regimen, dose and individual susceptibility.

Scalp cooling has been studied extensively as a method of reducing chemotherapy-induced alopecia. Cooling the scalp reduces local blood flow and cellular metabolic activity, potentially decreasing follicular exposure to chemotherapy. Systematic reviews and meta-analyses indicate that scalp cooling can reduce the likelihood of severe hair loss in some chemotherapy regimens, although effectiveness varies.

Psychological and Social Effects

Hair has strong cultural and personal significance. Consequently, hair loss can affect far more than physical appearance.

Studies of androgenetic alopecia and alopecia areata have documented effects on quality of life, body image, self-esteem, emotional well-being and social confidence. Depression and anxiety have also been examined in affected populations.

The psychological impact does not necessarily correspond directly to the medical severity of the hair loss. Relatively limited visible thinning may be highly distressing to one person while extensive hair loss may be less troubling to another.

Treatment decisions therefore often involve both biological disease control and the individual's personal goals and quality of life.

Current and Emerging Treatments

Hair-loss therapy increasingly depends on matching treatment to the biological cause rather than treating all thinning alike.

For androgenetic alopecia, research supports or investigates minoxidil, androgen-modifying medications, low-level light therapy, platelet-rich plasma and hair transplantation.

For alopecia areata, treatment can include corticosteroids, contact immunotherapy, systemic immune-directed therapy and JAK inhibitors.

For telogen effluvium, identifying and correcting the precipitating illness, nutritional problem, medication or physiological stress is generally central to management.

For traction alopecia, reducing mechanical tension is crucial before permanent scarring develops.

For inflammatory scarring alopecias, treatment focuses on suppressing follicular inflammation before irreversible destruction advances.

Research continues into fractional lasers, platelet-derived products, microneedling, biologic therapies and targeted small-molecule inhibitors. The evidence differs considerably among treatments and among different types of alopecia.

Regenerative Medicine and Future Research

Hair follicles are unusually dynamic organs capable of repeatedly regenerating throughout life. Their stem-cell populations and signaling networks have therefore become major targets of regenerative research.

Studies are examining how aging, oxidative stress, DNA damage, inflammation and changes in the follicular microenvironment alter hair-follicle stem-cell function. Mesenchymal stem cells, induced pluripotent stem cells, follicular cells and tissue-engineering approaches are also being investigated as possible future hair-restoration strategies.

Exosomes and other extracellular vesicles have received growing attention. These particles carry proteins, lipids and RNA molecules that can influence cellular signaling. Experimental work proposes that exosomes could influence WNT pathways, dermal papilla cells, angiogenesis, immune regulation and the duration of the anagen growth phase.

Clinical evidence for exosome-based hair restoration remains early, however. Research reviews emphasize problems such as variable cell sources, preparation methods, dosing, characterization and limited standardized clinical evidence.

The scalp and gut microbiome represent another emerging research field. Investigators are studying possible relationships between microbial communities, immune responses, inflammation and disorders including alopecia areata, androgenetic alopecia, central centrifugal cicatricial alopecia and lichen planopilaris.

Genomic research may also eventually improve prediction of individual risk and treatment response. Androgenetic alopecia is highly polygenic, while alopecia areata involves numerous immune-regulatory genes. Better understanding of these pathways could contribute to increasingly individualized therapies.

Conclusion

Human hair loss represents many biologically different disorders rather than a single condition. Pattern hair loss is strongly influenced by genetics and follicular responses to hormones, alopecia areata arises from immune attack on susceptible follicles, telogen effluvium reflects disruption of the normal growth cycle, and traction or toxic exposures can physically or chemically injure follicles. Scarring alopecias are particularly important to recognize early because follicular destruction can become permanent.

Modern evaluation combines clinical history and scalp examination with trichoscopy, laboratory investigation and, when necessary, scalp biopsy. Treatments now range from minoxidil, hormone-modifying medications and corticosteroids to JAK inhibitors, platelet-rich plasma, laser therapy, scalp cooling and hair transplantation.

At the same time, advances in genetics, immunology, stem-cell biology, biomaterials, microbiome research and extracellular-vesicle science are changing the understanding of how follicles grow, age, become inflamed and regenerate. These developments are shifting hair-loss research toward treatments directed at specific molecular and cellular mechanisms rather than hair loss as a single undifferentiated problem.

• • TOC**

Human Hair Loss

General Hair Loss and Diagnosis

Hair Loss

[MedlinePlus: Hair Loss | U.S. National Library of Medicine | MedlinePlus | 2025]

Provides a broad overview of alopecia, explaining normal daily shedding, hereditary hair loss, medical causes, medications, chemotherapy, and approaches to diagnosis and treatment.

Hair Loss: Overview

[AAD: Hair Loss Overview | American Academy of Dermatology | AAD | Updated]

Explains the distinction between ordinary shedding and pathological hair loss and describes hereditary loss, illness-related shedding, fungal infections, chemotherapy, and postpartum changes.

Hair Loss: Who Gets It and Causes

[AAD: Hair Loss Causes | American Academy of Dermatology | AAD | Updated]

Reviews major causes of human hair loss including androgenetic alopecia, aging, alopecia areata, scarring alopecia, thyroid disease, infection, medications, and nutritional problems.

Hair Loss: Diagnosis and Treatment

[AAD: Hair Loss Diagnosis and Treatment | American Academy of Dermatology | AAD | Updated]

Describes how dermatologists evaluate hair loss using medical history, scalp examination, hair-pull testing, laboratory studies, biopsy, and treatment based on the underlying cause.

Hair Loss: Tips for Managing

[AAD: Hair Loss Management | American Academy of Dermatology | AAD | Updated]

Discusses practical hair-care measures for people experiencing thinning or shedding and cautions against indiscriminate use of supplements marketed for hair growth.

Do You Have Hair Loss or Hair Shedding?

[AAD: Hair Loss or Hair Shedding | American Academy of Dermatology | AAD | Updated]

Explains how excessive shedding such as telogen effluvium differs from progressive forms of hair loss and why identifying the underlying process is important.

Hair Loss Resource Center

[AAD: Hair Loss Resource Center | American Academy of Dermatology | AAD | Updated]

Collects patient-oriented information on causes, forms, diagnosis, prevention, treatment, and management of common human hair-loss disorders.

How to Treat Hair Loss

[AAD: Hair Loss Treatment | American Academy of Dermatology | AAD | Updated]

Provides an overview of therapies used for several forms of alopecia, including minoxidil, corticosteroids, prescription medications, laser devices, and hair transplantation.

How to Diagnose Hair Loss

[PMID:23159173 | Adrianna J. Jackson and Vera H. Price | Dermatologic Clinics | 2013]

Presents a systematic diagnostic approach using medical history, scalp examination, hair-pull testing, laboratory studies, trichoscopy, and scalp biopsy.

Overview of Alopecia: A Dermatopathologist's Perspective

[PMCID:PMC6170065 | Leonard C. Sperling et al. | Journal of Clinical and Aesthetic Dermatology | 2018]

Reviews non-scarring and scarring alopecias from a pathology perspective and emphasizes the importance of distinguishing reversible follicular changes from permanent follicular destruction.

The Role of the Scalp Biopsy in the Evaluation of Alopecia

[PMID:37591560 | Leonard C. Sperling | Journal of the American Academy of Dermatology | 2023]

Explains when scalp biopsy is useful, how biopsy sites should be selected, and how tissue sampling differs between scarring and non-scarring alopecia.

The Scalp Biopsy for Hair Loss and Its Interpretation

[PMID:26176281 | Eleanor Knopp | Seminars in Cutaneous Medicine and Surgery | 2015]

Reviews biopsy technique, tissue processing, and histopathological interpretation for common causes of human hair loss.

Trichoscopy and Hair-Loss Assessment

Trichoscopy in Alopecias: Diagnosis Simplified

[PMID:24778525 | Nilam Jain, Bhavana Doshi and Uday Khopkar | International Journal of Trichology | 2013]

Reviews dermoscopic features that help distinguish androgenetic alopecia, alopecia areata, telogen effluvium, tinea capitis, trichotillomania, and scarring alopecias.

Trichoscopy: An Update

[PMID:36848957 | L. Fernández-Domper et al. | Actas Dermo-Sifiliográficas | 2023]

Summarizes newer trichoscopic findings used to diagnose common scalp and hair disorders without immediate need for invasive biopsy.

Trichoscopy: A New Method for Diagnosing Hair Loss

[PMID:18664157 | Lidia Rudnicka et al. | Journal of Drugs in Dermatology | 2008]

Describes the development of trichoscopy for visualizing follicular openings, hair shafts, pigmentation patterns, yellow dots, black dots, and other diagnostic features.

Trichoscopy of Androgenetic Alopecia: A Systematic Review

[PMID:38610726 | Agata Kuczara et al. | Journal of Clinical Medicine | 2024]

Identifies hair-diameter variability, vellus hairs, and the peripilar sign as particularly useful trichoscopic indicators of androgenetic alopecia.

A Three-Step Diagnostic Algorithm for Alopecia: Pattern Analysis in Trichoscopy

[PMID:40004726 | Multiple authors | Journal of Clinical Medicine | 2025]

Proposes a structured algorithm combining clinical pattern recognition and trichoscopic findings to differentiate major forms of alopecia.

Relevance of Trichoscopy in the Differential Diagnosis of Alopecia

[PMID:27297280 | Multiple authors | Indian Journal of Dermatology, Venereology and Leprology | 2016]

Examines how specific trichoscopic patterns can distinguish cicatricial from non-cicatricial alopecias and improve diagnostic confidence.

Hair Follicle Biology

The Follicle Cycle in Brief

[PMID:29797264 | Jeffrey E. Plowman and Duane P. Harland | Advances in Experimental Medicine and Biology | 2018]

Summarizes the anagen, catagen, and telogen phases through which hair follicles repeatedly cycle during normal human hair growth.

Review of Human Hair Follicle Biology

[PMID:30324295 | Gordon H. Sasaki | Aesthetic Plastic Surgery | 2019]

Reviews hair-follicle stem-cell niches, follicular cycling, androgenetic alopecia, and biological targets being investigated for hair regeneration.

Androgenetic Alopecia and Male-Pattern Hair Loss

Meta-analysis Identifies Novel Risk Loci and Yields Systematic Insights into the Biology of Male-Pattern Baldness

[Nature Communications Article 14694 | Stefanie Heilmann-Heimbach et al. | Nature Communications | 2017]

Reports a large genetic study identifying dozens of loci associated with male-pattern baldness and implicates pathways involving follicle development, signaling, and androgen biology.

Androgenetic Alopecia: A Review

[PMID:38826011 | Multiple authors | Nigerian Postgraduate Medical Journal | 2024]

Reviews the epidemiology, genetics, hormones, follicular miniaturization, diagnosis, systemic associations, and treatment of androgenetic alopecia.

What Is Male Pattern Hair Loss, and Can It Be Treated?

[AAD: Male Pattern Hair Loss | American Academy of Dermatology | AAD | Updated]

Explains the typical progression of male-pattern baldness and reviews treatments including minoxidil and finasteride.

Low-Level Laser Therapy for the Treatment of Androgenic Alopecia: A Review

[PMID:29270707 | Evan Darwin et al. | Lasers in Medical Science | 2018]

Reviews clinical trials of low-level laser therapy and finds evidence of increased hair density in some men and women with androgenetic alopecia.

Low-Level Laser Therapy as a Treatment for Androgenetic Alopecia

[PMID:27114071 | Multiple authors | Lasers in Surgery and Medicine | 2017]

Systematically reviews clinical evidence for low-level light therapy and discusses improvements reported in hair count, thickness, and patient satisfaction.

Comparative Effectiveness of Low-Level Laser Therapy for Adult Androgenic Alopecia

[PMID:30706177 | Multiple authors | Lasers in Medical Science | 2019]

Meta-analysis of randomized trials reports greater increases in hair density with low-level laser therapy than with sham treatment.

Low-Level Laser and LED Therapy in Alopecia

[PMID:39404126 | Multiple authors | Dermatologic Surgery | 2025]

Reviews low-level light therapy across androgenetic alopecia, alopecia areata, telogen effluvium, scarring alopecia, and chemotherapy-related hair loss.

Low-Level Laser Therapy for Treatment of Hair Loss

[PMID:23970445 | Michael R. Hamblin et al. | Lasers in Surgery and Medicine | 2014]

Reviews proposed biological mechanisms through which red and near-infrared light may affect follicular metabolism and hair growth.

Use of Low-Level Laser Therapy in Treatment of Androgenic Alopecia

[PMID:29227728 | Multiple authors | Journal of Cosmetic and Laser Therapy | 2018]

Systematically evaluates clinical evidence supporting low-level laser therapy as a non-surgical treatment for pattern hair loss.

Platelet-Rich Plasma for Androgenetic Alopecia

[PMID:37533146 | XiuXiu Zhang et al. | Journal of Cutaneous Medicine and Surgery | 2023]

Meta-analysis of randomized trials evaluates platelet-rich plasma injections and reports improvements in several measures of hair density.

Platelet-Rich Plasma as a Therapy for Androgenic Alopecia

[PMID:32410524 | Adam G. Evans et al. | Journal of Dermatological Treatment | 2022]

Reviews clinical studies of platelet-rich plasma and finds evidence suggesting improvements in hair density and hair thickness.

Platelet-Rich Plasma for Treating Androgenic Alopecia

[PMID:31187167 | Guangyu Mao, Guohui Zhang and Weixin Fan | Aesthetic Plastic Surgery | 2019]

Systematic review concludes that PRP may increase hair counts and density but emphasizes variability and limitations in existing studies.

Platelet-Rich Plasma for the Treatment of Alopecia

[PMID:34967722 | Multiple authors | Dermatologic Therapy | 2022]

Reviews controlled trials of platelet-rich plasma for androgenetic alopecia and alopecia areata while examining differences in preparation and treatment schedules.

The Role of Platelet-Rich Plasma in Androgenetic Alopecia

[PMID:38284294 | Multiple authors | Journal of Cosmetic Dermatology | 2024]

Reviews randomized and prospective studies of PRP in male androgenetic alopecia and finds promising but heterogeneous evidence.

Platelet-Rich Plasma in the Management of Alopecia

[PMID:40944844 | Multiple authors | Dermatology and Therapy | 2025]

Large systematic review and meta-analysis evaluates PRP treatment across dozens of randomized trials of alopecia.

PRP versus Topical Minoxidil for Androgenetic Alopecia

[PMID:41219547 | Multiple authors | Aesthetic Plastic Surgery | 2025]

Compares platelet-rich plasma with topical minoxidil and evaluates relative improvements and adverse effects.

Dutasteride Compared with Finasteride in Men with Androgenetic Alopecia

[PMID:30863034 | Multiple authors | Clinical Interventions in Aging | 2019]

Meta-analysis compares two 5-alpha-reductase inhibitors and reports greater short-term hair-count improvements with dutasteride in included studies.

Low-Dose Oral Minoxidil as Treatment for Non-Scarring Alopecia

[PMID:32516434 | Multiple authors | International Journal of Dermatology | 2020]

Reviews evidence for off-label low-dose oral minoxidil in androgenetic alopecia, female-pattern loss, telogen effluvium, and other non-scarring conditions.

Hair Transplantation: State of the Art

[PMID:40354670 | Multiple authors | Dermatologic Surgery | 2025]

Reviews modern follicular-unit transplantation and extraction techniques, donor selection, indications, instrumentation, and postoperative management.

The Psychological Consequences of Androgenetic Alopecia

[PMID:35403805 | Multiple authors | Journal of Cosmetic Dermatology | 2022]

Systematic review finds that pattern hair loss can affect quality of life, body image, and psychological well-being.

Psychosocial Impact of Androgenetic Alopecia on Men

[PMID:37605428 | Hannah Frith and Glen S. Jankowski | Psychology, Health & Medicine | 2024]

Reviews evidence on depression, anxiety, self-esteem, and quality of life among men experiencing androgenetic hair loss.

The Psychosocial Consequences of Androgenetic Alopecia: A Review

[PMID:10583042 | Multiple authors | British Journal of Dermatology | 1999]

Reviews research showing that visible hair loss can influence body image, social perceptions, and psychological adjustment.

Health-Related Quality of Life, Depression, and Self-Esteem in Androgenetic Alopecia

[PMID:34232264 | Multiple authors | JAMA Dermatology | 2021]

Meta-analysis examines quality-of-life impairment, emotional effects, depression measures, and self-esteem among people with androgenetic alopecia.

Role of Smoking in Androgenetic Alopecia

[PMID:35531482 | Yatra Kavadya and Venkataram Mysore | International Journal of Trichology | 2022]

Reviews evidence linking smoking with pattern hair loss through oxidative stress, vascular effects, DNA damage, and possible hormonal mechanisms.

The Effects of Smoking on Hair Health

[PMID:34307472 | Multiple authors | Skin Appendage Disorders | 2021]

Systematic review examines associations between smoking, androgenetic alopecia, frontal fibrosing alopecia, and premature hair graying.

Cellular Senescence: Ageing and Androgenetic Alopecia

[PMID:37088073 | Multiple authors | Skin Pharmacology and Physiology | 2023]

Explores how follicular aging, oxidative stress, dermal papilla senescence, and stem-cell dysfunction may contribute to androgenetic hair loss.

Micronutrients and Androgenetic Alopecia

[PMID:39440586 | Multiple authors | Molecular Nutrition & Food Research | 2024]

Reviews studies examining vitamin D, iron, zinc, B vitamins, selenium, copper, and other micronutrients in relation to pattern hair loss.

Female-Pattern Hair Loss

Female Pattern Hair Loss: A Comprehensive Review

[PMID:32700775 | Mia J. Bertoli et al. | Dermatologic Therapy | 2020]

Reviews pathogenesis, diagnosis, systemic associations, psychological effects, and established and emerging treatments for female-pattern hair loss.

Female-Pattern Hair Loss: Therapeutic Update

[PMID:37003900 | Paulo Müller Ramos et al. | Anais Brasileiros de Dermatologia | 2023]

Critically reviews topical minoxidil, oral therapies, procedural approaches, surgery, and camouflage methods for female-pattern hair loss.

An Updated Landscape of Female Pattern Hair Loss

[JAAD Reviews Volume 9 | Multiple authors | JAAD Reviews | 2026]

Reviews newer evidence concerning genetic architecture, hormones, environmental factors, micro-inflammation, epidemiology, and clinical classification of female-pattern hair loss.

The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis

[PMCID:PMC4000932 | Anja Vujovic and Véronique Del Marmol | BioMed Research International | 2014]

Reviews possible genetic and hormonal influences and describes clinical patterns used to diagnose female-pattern hair loss.

Female Pattern Hair Loss: A Clinical, Pathophysiologic, and Therapeutic Review

[PMCID:PMC6322157 | Multiple authors | International Journal of Women's Dermatology | 2018]

Discusses follicular miniaturization, diagnosis, hyperandrogenism, minoxidil, antiandrogens, and hair-restoration options.

Female Pattern Hair Loss

[PMID:26370643 | Dimitrios Ioannides and Elizabeth Lazaridou | Current Problems in Dermatology | 2015]

Provides an overview of diffuse crown and mid-frontal thinning in women and discusses its clinical and psychological consequences.

Relative Effect of 5-Alpha Reductase Inhibitors and Minoxidil for Female Pattern Hair Loss

[PMID:37386777 | Aditya K. Gupta et al. | Journal of Cosmetic Dermatology | 2024]

Network meta-analysis compares the relative effectiveness of minoxidil, finasteride, and dutasteride in adult women.

Untangling Estrogen Therapy for Menopausal Hair Loss

[PMID:42036029 | Eliana Farkas et al. | Journal of the American Academy of Dermatology | 2026]

Systematically reviews evidence concerning estrogen therapy, menopause, female-pattern hair loss, telogen effluvium, and related hair changes.

Alopecia Areata

Epidemiology of Alopecia Areata, Ophiasis, Totalis, and Universalis

[PMID:31437543 | Multiple authors | Journal of the American Academy of Dermatology | 2020]

Meta-analysis estimates the prevalence of alopecia areata and its major clinical subtypes across populations and age groups.

Alopecia Areata: What's New in Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Options?

[PMID:27765435 | Multiple authors | Journal of Dermatological Science | 2016]

Reviews autoimmune mechanisms, genetic susceptibility, epidemiology, diagnosis, and emerging targeted treatments for alopecia areata.

An Updated Review on Current Treatment of Alopecia Areata and Newer Therapeutic Options

[PMID:37305188 | Karan Malhotra and Bhushan Madke | International Journal of Trichology | 2023]

Reviews corticosteroids, immunotherapy, systemic treatments, JAK inhibitors, and other developing therapies for alopecia areata.

Alopecia Areata: Diagnosis and Treatment

[AAD: Alopecia Areata Treatment | American Academy of Dermatology | AAD | Updated]

Describes clinical diagnosis and treatment approaches ranging from observation and corticosteroid injections to systemic treatment for more extensive disease.

New U.S. Treatment Recommendations for Severe Alopecia Areata in Adults

[NAAF Treatment Recommendations | National Alopecia Areata Foundation | NAAF | 2026]

Summarizes the first U.S. expert-consensus recommendations addressing treatment selection and standards of care for adults with severe alopecia areata.

New U.S. Treatment Recommendations Published for Adults with Severe Alopecia Areata

[NAAF News | National Alopecia Areata Foundation | NAAF | September 3, 2026]

Reports publication of U.S. expert consensus guidance intended to improve consistency in treatment of severe alopecia areata.

Bempikibart Phase 2 Results for Severe Alopecia Areata

[NAAF News | National Alopecia Areata Foundation | NAAF | 2026]

Describes Phase 2 trial results for an investigational antibody targeting IL-7 and TSLP pathways as a possible alternative immune strategy to JAK inhibition.

Funded Research

[NAAF Research Program | National Alopecia Areata Foundation | NAAF | Updated]

Summarizes research projects investigating immune mechanisms, genetics, transcriptomics, treatment targets, and psychosocial consequences of alopecia areata.

Telogen Effluvium and Diffuse Hair Shedding

Telogen Effluvium: A Review of the Science and Current Obstacles

[PMID:33541773 | Multiple authors | Journal of Dermatological Science | 2021]

Reviews mechanisms, diagnosis, triggers, treatment limitations, and research questions surrounding acute and chronic telogen effluvium.

Telogen Effluvium: A 360 Degree Review

[PMID:38015483 | Multiple authors | Italian Journal of Dermatology and Venereology | 2023]

Reviews stress, illness, COVID-19, differential diagnosis, clinical findings, and current approaches to telogen effluvium.

Alopecia in Patients with COVID-19

[PMID:35224518 | Betty Nguyen and Antonella Tosti | JAAD International | 2022]

Systematic review examines androgenetic alopecia, alopecia areata, and especially telogen effluvium reported in association with COVID-19.

Characteristics of Hair Loss after COVID-19

[PMID:35801366 | Multiple authors | Journal of Cosmetic Dermatology | 2022]

Scoping review finds that post-COVID hair loss most often resembles telogen effluvium and frequently begins several weeks after infection.

Medication-Induced Hair Loss: An Update

[PMID:37591561 | Lina Alhanshali et al. | Journal of the American Academy of Dermatology | 2023]

Reviews medications associated with anagen effluvium, telogen effluvium, alopecia areata-like reactions, and other forms of drug-related hair loss.

Drug-Induced Alopecia: Review of the Literature

[PMID:7631289 | Multiple authors | Therapie | 1995]

Reviews medications historically associated with diffuse hair shedding, including psychotropics, anticonvulsants, anticoagulants, retinoids, and hormonal drugs.

Biotin for Hair Loss: Teasing Out the Evidence

[PMID:39148962 | Allyson Yelich et al. | Journal of Clinical and Aesthetic Dermatology | 2024]

Reviews clinical evidence for biotin supplementation and concludes that strong evidence supporting routine biotin use for hair growth is lacking.

Traction and Mechanical Hair Loss

Traction Alopecia

[DermNet: Traction Alopecia | Anila Kapadia | DermNet | 2014]

Explains how prolonged or repetitive tension from braids, extensions, ponytails, and other hairstyles can produce initially reversible and eventually scarring hair loss.

Traction Alopecia: The Root of the Problem

[PMID:29670386 | Victoria Billero and Mariya Miteva | Clinical, Cosmetic and Investigational Dermatology | 2018]

Reviews epidemiology, high-risk hairstyling practices, clinical progression, prevention, and treatment of traction alopecia.

Traction Alopecia

[PMID:29262008 | Multiple authors | StatPearls | Updated 2025]

Reviews clinical features, diagnosis, hair casts, follicular miniaturization, prevention, and treatment of traction-induced hair loss.

Hairstyles That Pull Can Lead to Hair Loss

[AAD: Hairstyles and Hair Loss | American Academy of Dermatology | AAD | Updated]

Provides practical guidance on preventing traction alopecia by reducing chronic tension from tight hairstyles, braids, weaves, and extensions.

Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia: A Deeper Insight into the Disease

[PMID:38383911 | Syeda Zainab Fatima | Wiener Medizinische Wochenschrift | 2024]

Reviews pathogenesis, presentation, quality-of-life effects, treatment barriers, and research needs for CCCA.

Central Centrifugal Cicatricial Alopecia: Challenges and Solutions

[PMCID:PMC4993262 | Ilana Herskovitz and Mariya Miteva | Clinical, Cosmetic and Investigational Dermatology | 2016]

Reviews genetics, hairstyling factors, dermoscopy, biopsy, inflammatory mechanisms, and management of CCCA.

Central Centrifugal Cicatricial Alopecia: What Has Been Achieved, Current Clues for Future Research

[PMID:24680004 | Temitayo A. Ogunleye et al. | Dermatologic Clinics | 2014]

Reviews epidemiology and possible genetic, structural, androgenic, and inflammatory contributions to CCCA.

Central Centrifugal Cicatricial Alopecia: Past, Present, and Future

[PMID:19293013 | Multiple authors | Journal of the American Academy of Dermatology | 2009]

Traces changing theories about CCCA from the older concept of hot-comb alopecia toward broader genetic and biological explanations.

Central Centrifugal Cicatricial Alopecia: New Insights and a Call for Action

[PMID:28941495 | Multiple authors | International Journal of Women's Dermatology | 2017]

Reviews inheritance, inflammatory pathology, hairstyling influences, quality-of-life effects, and the need for larger genetic studies.

Frontal Fibrosing Alopecia and Lichen Planopilaris

Approach to Scarring Alopecia

[JAMA Dermatology DOI:10.1001/jamadermatol.2025.3540 | Jiana Wyche, Maryanne Senna and Crystal Aguh | JAMA Dermatology | 2025]

Provides a practical approach to recognizing and treating major lymphocytic and neutrophilic forms of irreversible scarring alopecia.

Primary Scarring Alopecia: Clinical-Pathological Review

[PMCID:PMC5582480 | Multiple authors | International Journal of Trichology | 2017]

Reviews clinical and pathological findings in lichen planopilaris, frontal fibrosing alopecia, lupus-related alopecia, and other cicatricial disorders.

Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes

[PMID:29056083 | Derek To and Jennifer Beecker | Journal of Cutaneous Medicine and Surgery | 2018]

Reviews etiopathogenesis, clinical presentation, pathology, and treatment options for frontal fibrosing alopecia.

Frontal Fibrosing Alopecia: A Review of 60 Cases

[PMID:22503342 | Alison MacDonald, Colin Clark and Susan Holmes | Journal of the American Academy of Dermatology | 2012]

Examines clinical patterns and characteristics in a series of patients with progressive frontotemporal scarring hair loss.

Frontal Fibrosing Alopecia: A Review and Practical Guide for Clinicians

[PMID:35767748 | Klementyna Kępińska et al. | Annals of Agricultural and Environmental Medicine | 2022]

Provides practical guidance on diagnosis, environmental theories, clinical features, and therapeutic strategies for FFA.

Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates

[PMID:40162350 | Multiple authors | Indian Journal of Dermatology | 2025]

Reviews immune privilege, genetics, hormones, environmental hypotheses, trichoscopy, histology, and therapy.

Frontal Fibrosing Alopecia in Men

[PMID:40142720 | Multiple authors | Dermatology Reports | 2025]

Reviews the less-recognized male presentation of FFA, including beard involvement, eyebrow loss, and confusion with androgenetic alopecia.

Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris

[PMID:23531029 | E. Rácz et al. | Journal of the European Academy of Dermatology and Venereology | 2013]

Systematic review examines therapies used for FFA and lichen planopilaris and highlights the historically weak evidence base.

Therapeutic Management of Classic Lichen Planopilaris

[PMID:29520159 | Enzo Errichetti et al. | Clinical, Cosmetic and Investigational Dermatology | 2018]

Systematic review assesses available treatment strategies for classic lichen planopilaris and proposes an evidence-informed therapeutic approach.

Medical Therapies for Lichen Planopilaris

[PMID:37852211 | Multiple authors | Skin Appendage Disorders | 2024]

Network meta-analysis compares treatments used to reduce inflammatory activity and progression in lichen planopilaris.

Management of Classic Lichen Planopilaris: EADV Position Statement

[PMID:41848299 | EADV Task Force on Hair Diseases | Journal of the European Academy of Dermatology and Venereology | 2026]

Provides expert recommendations for topical, intralesional, systemic, and combination therapy aimed at limiting permanent follicular destruction.

Other Scarring Alopecias

Folliculitis Decalvans: A Multicentre Review of 82 Patients

[PMID:25682915 | S. Vañó-Galván et al. | Journal of the European Academy of Dermatology and Venereology | 2015]

Reviews epidemiology, diagnosis, associated conditions, and treatment outcomes in a large series of patients with neutrophilic scarring alopecia.

Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances

[PMID:41945009 | Luca Valtellini et al. | American Journal of Clinical Dermatology | 2026]

Reviews pathogenesis, diagnosis, follicular-occlusion biology, conventional therapy, biologics, and emerging treatments for this destructive scalp disorder.

Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy

[PMID:41898217 | Multiple authors | Review Article | 2026]

Connects inflammatory mechanisms in dissecting cellulitis with systemic retinoids, antibiotics, biologics, JAK inhibitors, and other targeted therapies.

Treatments for Dissecting Cellulitis of the Scalp

[PMID:37740150 | Rahul Masson et al. | Dermatology and Therapy | 2023]

Systematic review evaluates antibiotics, retinoids, biologics, photodynamic therapy, surgery, and other reported interventions.

Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis

[PMID:41964799 | Multiple authors | Dermatology and Therapy | 2026]

Reviews biologics and targeted small-molecule therapies for refractory dissecting cellulitis within the follicular-occlusion spectrum.

Dissecting Cellulitis of the Scalp: Review and Surgical Reconstruction

[PMID:32983774 | Trajan A. Cuellar et al. | Plastic and Reconstructive Surgery Global Open | 2020]

Reviews advanced dissecting cellulitis and describes surgical approaches for severe disease that has produced extensive scarring alopecia.

Dissecting Cellulitis of the Scalp: Clinical Characteristics and Management

[PMID:35674720 | Marta Gamissans et al. | Dermatologic Therapy | 2022]

Reviews clinical presentation and treatment experience in a series of patients with this chronic inflammatory scalp disorder.

Infectious and Secondary Alopecia

Syphilitic Alopecia: Five Cases and Review of the Literature

[PMID:22749730 | P. Hernández-Bel et al. | Actas Dermo-Sifiliográficas | 2013]

Reviews the uncommon moth-eaten and diffuse patterns of hair loss that can occur during secondary syphilis and resolve following appropriate treatment.

Chemotherapy-Induced Hair Loss

Scalp Hypothermia to Reduce Chemotherapy-Induced Alopecia

[PMID:38936283 | Multiple authors | Gynecologic Oncology | 2024]

Meta-analysis reviews scalp cooling in people receiving taxane chemotherapy and evaluates its ability to reduce severe chemotherapy-related alopecia.

Scalp Hypothermia for Preventing Alopecia During Chemotherapy

[PMID:28939291 | Hope S. Rugo and Jeffrey Voigt | Clinical Breast Cancer | 2018]

Systematic review and meta-analysis examines randomized trials of scalp cooling for prevention of chemotherapy-induced hair loss.

Scalp Cooling: Efficacy, Safety, and Tolerability

[PMID:28315539 | Multiple authors | Clinical Journal of Oncology Nursing | 2017]

Reviews decades of research on scalp cooling, including hair preservation, tolerability, and concerns about scalp metastasis.

Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia

[PMID:36999663 | Multiple authors | Systematic Review and Meta-analysis | 2023]

Finds that scalp cooling reduces the risk of severe chemotherapy-related alopecia across multiple studies and cooling systems.

Scalp Cooling Therapy in Chemotherapy-Induced Alopecia

[PMID:41174233 | Multiple authors | Review Article | 2025]

Examines variability in precooling and post-cooling times, chemotherapy regimen effects, patient factors, and strategies for improving scalp-cooling efficiency.

Additional Population and Treatment Research

Pediatric Androgenetic Alopecia: A Review

[PMID:31415838 | Multiple authors | Journal of the American Academy of Dermatology | 2020]

Reviews reported androgenetic alopecia in children and adolescents and highlights the need to distinguish early pattern loss from other pediatric alopecias.

A Systematic Review of Procedural Modalities in Lichen Planopilaris, FFA, and Discoid Lupus Alopecia

[PMID:41081974 | Ali Ezzatollahi Tanha et al. | Lasers in Medical Science | 2025]

Reviews lasers, platelet products, microneedling, injections, hair transplantation, and other procedural approaches used in selected scarring alopecias.

Mycophenolate Mofetil and Lichen Planopilaris

[PMID:32281437 | Niyaz Mostafa, Kevin Phan and Saxon Smith | Journal of Dermatological Treatment | 2020]

Systematic review evaluates mycophenolate mofetil as an option for severe or treatment-resistant lichen planopilaris.

Topical JAK Inhibitors in the Lichen Planus Spectrum

[PMID:42235480 | Multiple authors | Annales de Dermatologie et de Vénéréologie | 2026]

Reviews emerging evidence for topical JAK inhibitors in lichen planopilaris, frontal fibrosing alopecia, and related inflammatory disorders.

Lichen Planopilaris Induced by Checkpoint Inhibitors

[PMID:41386655 | Niyoosha Yoosefi, Adrian Tabari and Jeffrey Donovan | International Journal of Dermatology | 2026]

Reviews reported lichen planopilaris associated with immune-checkpoint cancer therapies and highlights medication-induced pathways to scarring hair loss.

Dissecting Cellulitis of the Scalp: A Case Report and Review

[PMID:41664784 | Multiple authors | Cureus | 2026]

Reviews the presentation of painful nodules, draining sinus tracts, permanent scarring, and racial disparities associated with dissecting cellulitis.

Dissecting Cellulitis of the Scalp and Spondyloarthritis

[PMID:35460009 | Nicole Zagelbaum et al. | Clinical Rheumatology | 2022]

Discusses an inflammatory association between dissecting cellulitis and musculoskeletal disease while reviewing the broader literature on the disorder.

Dissecting Cellulitis of the Scalp

[PMID:3513219 | C. N. Williams et al. | Plastic and Reconstructive Surgery | 1986]

Classic report describes the painful nodules, interconnected abscesses, drainage, and cicatricial alopecia characteristic of advanced dissecting cellulitis.

Hair Cortisol, Stress Exposure, and Mental Health in Humans

[PMID:23253896 | Sabine M. Staufenbiel et al. | Psychoneuroendocrinology | 2013]

Reviews hair cortisol as a long-term biological marker of stress, providing useful background for research into interactions between chronic stress physiology and hair biology.

Human Hair Loss — Additional Research

General Hair Loss, Diagnosis, and Epidemiology

Hair Loss: Diagnosis and Treatment

[AAFP 2024 | MaryAnn Dakkak, Klive M. Forde, Howard Lanney | American Family Physician | 2024]

Reviews a practical diagnostic framework for diffuse, patterned, and focal hair loss and discusses telogen effluvium, androgenetic alopecia, alopecia areata, tinea capitis, traction alopecia, systemic causes, and treatment.

Hair Loss: Common Causes and Treatment

[PMID:28925637 | T. Grant Phillips, W. Paul Slomiany, Robert Allison | American Family Physician | 2017]

Provides a primary-care-oriented overview of common nonscarring alopecias and explains how history, examination, distribution, and associated symptoms help distinguish major causes.

Alopecia

[PMID:30844205 | Hasnain A. Syed, Patrick M. Zito | StatPearls / NCBI Bookshelf | 2024]

Summarizes the major categories of alopecia, including androgenetic, autoimmune, traumatic, infectious, toxic, nutritional, and scarring forms.

Androgenetic Alopecia

[PMID:41068174 | Yingzi Liu et al. | Nature Reviews Disease Primers | 2025]

Provides a modern synthesis of androgenetic alopecia epidemiology, molecular mechanisms, genetic susceptibility, follicular miniaturization, diagnosis, disease burden, and current therapeutic approaches.

Androgenetic Alopecia: A Review

[PMID:28349362 | Multiple authors | Endocrine | 2017]

Reviews endocrine and genetic mechanisms involved in pattern hair loss, emphasizing androgen signaling, inherited susceptibility, and progressive transformation of terminal follicles.

Genetics and Biology of Androgenetic Alopecia

The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives

[PMID:41594927 | Aditya K. Gupta et al. | Biology | 2026]

Reviews hundreds of genetic associations with androgenetic alopecia and discusses androgen signaling, WNT pathways, extracellular-matrix biology, ancestry differences, and prospects for personalized treatment.

Genetic and Molecular Aspects of Androgenetic Alopecia

[PMID:29595184 | Multiple authors | Indian Journal of Dermatology, Venereology and Leprology | 2018]

Examines molecular and genetic discoveries explaining why susceptible follicles progressively miniaturize under androgen influence.

Androgenetic Alopecia in Men: An Update on Genetics

[PMID:39119311 | Ilakkia Priya Sadasivam et al. | Indian Journal of Dermatology | 2024]

Reviews polygenic inheritance, androgen receptor pathways, candidate genes, genome-wide association findings, and genetic susceptibility to male-pattern hair loss.

Risk Factors for Androgenetic Alopecia: A Systematic Review and Meta-analysis

[PMID:41606541 | Haoyang Li et al. | BMC Public Health | 2026]

Quantifies associations between androgenetic alopecia and family history, smoking, insulin resistance, fasting insulin, and other proposed risk factors.

Systematic Review and Meta-analysis of the Association Between Metabolic Syndrome and Androgenetic Alopecia

[PMID:34935992 | Yueqi Qiu et al. | Acta Dermato-Venereologica | 2022]

Finds that androgenetic alopecia is associated in observational research with metabolic syndrome and adverse measures of glucose regulation, obesity, lipids, and blood pressure.

Association Between Androgenetic Alopecia and Metabolic Syndrome: A Meta-analysis

[PMID:25372648 | Da-xing Wu et al. | Zhejiang University Medical Journal | 2014]

Evaluates earlier evidence suggesting that people with androgenetic alopecia have higher rates of metabolic syndrome than comparison populations.

A Meta-analysis Study on the Association Between Smoking and Male Pattern Hair Loss

[PMID:38174368 | Multiple authors | PubMed-indexed Meta-analysis | 2024]

Reports that male smokers have higher odds of developing androgenetic alopecia and examines whether heavier smoking is associated with progression.

Hair Density, Hair Diameter and the Prevalence of Female Pattern Hair Loss

[PMID:11251562 | Multiple authors | British Journal of Dermatology | 2001]

Measures age-related changes in hair density and diameter and documents increasing prevalence of female-pattern hair loss in older women.

Prevalence of Female Pattern Hair Loss in Postmenopausal Women: A Cross-sectional Study

[PMID:35357365 | Multiple authors | Menopause | 2022]

Examines the prevalence and severity of female-pattern hair loss among postmenopausal women and evaluates demographic, hormonal, and metabolic associations.

A Practical Approach to the Management of Hair Loss in Patients with Polycystic Ovary Syndrome

[PMID:36606524 | Multiple authors | Journal of the European Academy of Dermatology and Venereology | 2023]

Reviews diagnosis and treatment of female-pattern hair loss in women with PCOS, where hyperandrogenism and metabolic abnormalities can complicate management.

Female Pattern Hair Loss and Polycystic Ovarian Syndrome: More Than Just Hirsutism

[PMID:36226726 | Multiple authors | Current Opinion in Endocrinology, Diabetes and Obesity | 2023]

Discusses female-pattern hair loss as an underrecognized manifestation of PCOS and examines hormonal evaluation and therapeutic considerations.

Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction

[PMID:42096403 | Multiple authors | PubMed-indexed Review | 2026]

Proposes that hair loss in PCOS reflects interactions between androgen signaling, insulin resistance, chronic inflammation, genetics, and local follicular metabolism.

Nutrition, Vitamins, and Mineral Status

Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-analysis

[PMID:35415182 | Yulia Treister-Goltzman, Shaked Yarza, Roni Peleg | Skin Appendage Disorders | 2022]

Analyzes studies of ferritin and iron deficiency in women with nonscarring hair loss and finds lower average ferritin concentrations among affected women.

Iron Deficiency and Diffuse Nonscarring Scalp Alopecia in Women: More Pieces to the Puzzle

[PMID:20888064 | Multiple authors | Journal of the American Academy of Dermatology | 2010]

Reviews evidence linking low iron stores with diffuse hair loss and discusses iron-dependent genes expressed in the hair-follicle stem-cell region.

The Diagnosis and Treatment of Iron Deficiency and Its Potential Relationship to Hair Loss

[PMID:16635664 | Leonid Benjamin Trost, Wilma Fowler Bergfeld, Ellen Calogeras | Journal of the American Academy of Dermatology | 2006]

Reviews conflicting evidence surrounding iron deficiency and alopecia and discusses appropriate laboratory assessment and cautious iron replacement.

Association Between Serum Zinc Levels and Androgenetic Alopecia: A Systematic Review and Meta-analysis

[PMID:34708926 | Hua-Ching Chang, Yin-Shuo Chang | Journal of Cosmetic Dermatology | 2022]

Pools observational evidence evaluating whether serum zinc concentrations differ between people with androgenetic alopecia and controls.

Vitamin D Deficiency in Non-scarring and Scarring Alopecias: A Systematic Review and Meta-analysis

[PMID:39416654 | Multiple authors | PubMed-indexed Systematic Review | 2024]

Compares vitamin D status across alopecia areata, female-pattern hair loss, male androgenetic alopecia, telogen effluvium, and primary scarring alopecias.

Serum 25-Hydroxyvitamin D in Non-scarring Alopecia: A Systematic Review and Meta-analysis

[PMID:38010941 | Yuling Chen et al. | Journal of Cosmetic Dermatology | 2024]

Finds lower vitamin D concentrations and higher rates of deficiency among people with several nonscarring alopecias compared with controls.

Telogen Effluvium, Illness, Weight Loss, and Toxic Hair Loss

Telogen Effluvium: A Review of the Literature

[PMID:32607303 | Fahham Asghar et al. | Cureus | 2020]

Reviews causes of excessive telogen shedding including physiologic stress, emotional stress, illness, medications, nutritional abnormalities, endocrine disorders, and surgery.

Telogen Effluvium: A Review

[PMID:26500992 | Shashikant Malkud | Journal of Clinical and Diagnostic Research | 2015]

Describes hair-cycle disturbances that produce diffuse shedding and reviews recognized triggers, diagnostic features, prognosis, and management.

Global Epidemiology of Telogen Effluvium After the COVID-19 Pandemic: A Systematic Review and Modeling Study

[PMID:39582806 | Jae Joon Jeon et al. | JAAD International | 2025]

Examines worldwide changes in telogen effluvium following the COVID-19 pandemic and estimates the broader epidemiological burden of post-infectious shedding.

A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

[PMID:34931698 | Multiple authors | Journal of Medical Virology | 2022]

Reviews reported post-COVID telogen effluvium cases, including onset timing, trichoscopic findings, clinical course, and eventual recovery.

Hair Loss and Metabolic and Bariatric Surgery: An Updated Systematic Review and Meta-analysis

[PMID:40388098 | Nima Taghizadeh et al. | Obesity Surgery | 2025]

Analyzes thousands of bariatric-surgery patients and finds postoperative hair loss to be a common complication whose frequency differs among surgical procedures.

Hair Loss After Metabolic and Bariatric Surgery: A Systematic Review and Meta-analysis

[PMID:33675022 | Wen Zhang et al. | Obesity Surgery | 2021]

Links post-bariatric hair shedding with rapid weight loss and lower zinc, folate, and ferritin levels in some patient groups.

Association of Obesity and Bariatric Surgery on Hair Health

[PMID:38399612 | Multiple authors | PubMed-indexed Review | 2024]

Reviews how obesity, rapid weight reduction, surgical stress, reduced protein intake, and micronutrient deficiencies can alter normal hair cycling.

Bariatric Surgery-Induced Telogen Effluvium: Case Report and a Review of Hair Loss Following Weight Loss Surgery

[PMID:34055500 | Rena A. Cohen-Kurzrock, Philip R. Cohen | Cureus | 2021]

Distinguishes early postoperative telogen effluvium from later hair loss associated with nutritional deficiencies after bariatric surgery.

Anagen Effluvium

[PMID:23974578 | Multiple authors | International Journal of Trichology | 2013]

Reviews abrupt loss of actively growing hairs caused by chemotherapy, radiation, toxic chemicals, and severe inflammatory injury to rapidly dividing follicular cells.

Tinea Capitis: An Updated Review

[PMID:31906842 | Multiple authors | PubMed-indexed Review | 2020]

Reviews dermatophyte infection of the scalp, including gray-patch alopecia, black-dot alopecia, kerion, diagnostic testing, and systemic antifungal therapy.

Traction Alopecia: A Neglected Entity

[PMID:29035284 | Multiple authors | Indian Journal of Dermatology, Venereology and Leprology | 2017]

Explains how chronic mechanical tension produces initially reversible follicular injury that can progress to irreversible scarring hair loss.

Management of Traction Alopecia: Our Experience and a Brief Review of Current Literature Recommendations

[PMID:33938696 | Lisa Akintilo et al. | Journal of Drugs in Dermatology | 2021]

Reviews modification of damaging hairstyles and medical approaches intended to reduce inflammation and encourage regrowth before permanent scarring develops.

Traction Alopecia: Assessing the Presentation, Management and Outcomes in a Diverse Urban Population

[PMID:37098178 | Eliza Balazic et al. | Clinical and Experimental Dermatology | 2023]

Examines demographic patterns, hairstyling history, clinical findings, treatments, and outcomes in more than 200 patients with traction alopecia.

Dermoscopy of Traction Alopecia in Black Scalp Patients: Insights from a Literature Review

[PMID:40401872 | Multiple authors | PubMed-indexed Literature Review | 2025]

Reviews trichoscopic signs including hair casts, broken hairs, black dots, vellus hairs, reduced density, and empty follicular openings.

Scarring and Inflammatory Alopecia

Systemic Comorbidities in Central Centrifugal Cicatricial Alopecia: A Systematic Review and Meta-analysis

[PMID:42549602 | Juan Luis Sanz-Cabanillas et al. | Acta Dermato-Venereologica | 2026]

Evaluates evidence linking CCCA with cardiometabolic, fibroproliferative, and other systemic disorders.

Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021

[PMID:36399228 | Elisabeth A. George et al. | American Journal of Clinical Dermatology | 2023]

Reviews a decade of progress in understanding genetic susceptibility, environmental influences, inflammation, diagnosis, and treatment of CCCA.

Lessons from a Scoping Review: Clinical Presentations of Central Centrifugal Cicatricial Alopecia

[PMID:38521463 | Yacine N. Sow et al. | Journal of the American Academy of Dermatology | 2024]

Shows that CCCA can occur in distributions beyond the classic central-vertex pattern, including frontal, temporal, occipital, parietal, and patchy forms.

Central Centrifugal Cicatricial Alopecia: An Approach to Diagnosis and Management

[PMID:22097988 | Multiple authors | International Journal of Dermatology | 2011]

Discusses differentiation of CCCA from female-pattern hair loss, alopecia areata, lichen planopilaris, and telogen effluvium.

Updates in Therapeutics for Folliculitis Decalvans: A Systematic Review with Evidence-based Analysis

[PMID:30092322 | Pooja H. Rambhia et al. | Journal of the American Academy of Dermatology | 2019]

Reviews antibiotics, retinoids, corticosteroids, biologic treatments, and other therapies used to control folliculitis decalvans and prevent additional scarring.

Management of Folliculitis Decalvans: A Systematic Review

[PMID:41146582 | Emily Sideris et al. | Australasian Journal of Dermatology | 2025]

Evaluates newer treatment evidence for folliculitis decalvans and tufted hair folliculitis, both recurrent inflammatory disorders capable of destroying follicles.

Non-scarring Alopecia of Lupus Erythematosus: A Comprehensive Review

[PMID:37598015 | A. Perales et al. | Annales de Dermatologie et de Vénéréologie | 2023]

Reviews diffuse alopecia, patchy alopecia, lupus hair, and other nonscarring forms of hair loss associated with lupus erythematosus.

Lichen Planopilaris and the Lichen Planopilaris Mimickers: A Systematic Review

[PMID:40205646 | Kimia Ameri et al. | International Journal of Dermatology | 2025]

Reviews disorders capable of resembling lichen planopilaris and highlights clinical, trichoscopic, and histopathological clues useful for differential diagnosis.

Lichen Planopilaris After Hair Transplantation and Facial Surgical Procedures: A Systematic Review

[PMID:42484473 | Jorge Lázaro Escudero et al. | Dermatologic Surgery | 2026]

Reviews reported lichen planopilaris developing after hair transplantation or facial procedures and explores trauma as a possible inflammatory trigger.

Alopecia Areata — Systemic Associations and Quality of Life

Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis

[PMID:37464249 | Sophia Ly et al. | American Journal of Clinical Dermatology | 2023]

Analyzes more than 100 studies and identifies increased rates of several autoimmune, metabolic, inflammatory, and nutritional disorders among people with alopecia areata.

Comorbidities in Alopecia Areata: A Systematic Review and Meta-analysis

[PMID:30031145 | Multiple authors | Journal of the American Academy of Dermatology | 2019]

Reviews associations between alopecia areata and thyroid disease, atopy, lupus, metabolic syndrome, vitamin D deficiency, psychiatric disorders, and other conditions.

Increased Incidence of Thyroid Disease in Patients with Alopecia Areata: A Systematic Review and Meta-analysis

[PMID:31618741 | Multiple authors | Dermatology | 2020]

Finds a substantially higher prevalence of thyroid disease among patients with alopecia areata compared with controls.

Alopecia Areata and Health-related Quality of Life: A Systematic Review and Meta-analysis

[PMID:26914830 | F. Rencz et al. | British Journal of Dermatology | 2016]

Shows significant impairment in emotional well-being, vitality, mental health, and dermatology-specific quality of life among adults with alopecia areata.

Pediatric Alopecia Areata

Therapeutic Management in Paediatric Alopecia Areata: A Systematic Review

[PMID:33630354 | A. Waśkiel-Burnat et al. | Journal of the European Academy of Dermatology and Venereology | 2021]

Reviews corticosteroids, contact immunotherapy, anthralin, JAK inhibitors, phototherapy, methotrexate, minoxidil, and other treatments studied in children.

Treatment of Pediatric Alopecia Areata: A Systematic Review

[PMID:33940103 | Virginia R. Barton et al. | Journal of the American Academy of Dermatology | 2022]

Evaluates more than 100 reports on pediatric alopecia areata and identifies topical corticosteroids as having the strongest conventional evidence base.

Pathophysiology of Alopecia Areata in the Pediatric Patient

[PMID:40044623 | Multiple authors | Pediatric Dermatology | 2025]

Explains genetic susceptibility, collapse of follicular immune privilege, interferon signaling, JAK-STAT activation, and cytotoxic T-cell attack in childhood disease.

Alopecia Areata — Immunology and Pathogenesis

Immunopathogenesis of Alopecia Areata

[PMID:35492401 | Jadesola Jadé Temitope Olayinka, Jillian M. Richmond | Current Research in Immunology | 2021]

Reviews immune-privilege collapse and the T cells, cytokines, chemokines, and inflammatory signaling pathways that drive follicular attack.

Biomarkers in Alopecia Areata: A Systematic Review and Meta-analysis

[PMID:37087083 | Multiple authors | PubMed-indexed Systematic Review | 2023]

Evaluates dozens of circulating biomarkers and identifies altered interleukin-6, C-reactive protein, vitamin D, and other inflammatory markers.

Alopecia Areata: Current Understanding of the Pathophysiology and Update on Therapeutic Approaches

[PMID:34709679 | Masahiro Fukuyama, Taisuke Ito, Manabu Ohyama | Journal of Dermatology | 2022]

Integrates immune-privilege collapse, cytotoxic lymphocytes, inflammatory signaling, environmental triggers, and Japanese treatment recommendations.

Alopecia Areata: A Review of Disease Pathogenesis

[PMID:29791718 | Multiple authors | British Journal of Dermatology | 2018]

Reviews evidence for autoimmune attack against follicles and discusses dendritic cells, natural killer cells, T cells, interferon-gamma, IL-15, MICA, and NKG2D.

Alopecia Areata: Disease Characteristics, Clinical Evaluation, and New Perspectives on Pathogenesis

[PMID:29241771 | Multiple authors | Journal of the American Academy of Dermatology | 2018]

Reviews clinical subtypes, prognosis, epidemiology, psychological consequences, immune mechanisms, genetics, and disease evaluation.

The Role of Hair Follicle Immune Privilege Collapse in Alopecia Areata: Status and Perspectives

[PMID:24326544 | Multiple authors | Experimental Dermatology | 2014]

Develops the model in which inflammatory signals expose normally protected follicular antigens to cytotoxic immune cells.

Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management

[PMID:34403083 | Multiple authors | Dermatology and Therapy | 2021]

Summarizes genetic and environmental contributions to immune-privilege failure and reviews clinical patterns and conventional therapies.

Alopecia Areata: A Review on Diagnosis, Immunological Etiopathogenesis and Treatment Options

[PMID:33386567 | A. Sterkens, J. Lambert, A. Bervoets | Clinical Reviews in Allergy & Immunology | 2021]

Reviews autoimmune mechanisms alongside topical, intralesional, systemic, immunotherapeutic, and emerging targeted treatments.

Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management

[PMID:29273098 | Multiple authors | Journal of Investigative Dermatology Symposium Proceedings | 2018]

Argues that restoring the immune-protected environment of the anagen hair bulb represents a potentially important therapeutic strategy.

Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches

[PMID:36670997 | Lucia Peterle et al. | Antioxidants | 2023]

Explores oxidative damage as a contributor to immune-privilege breakdown and discusses antioxidant pathways and potential biomarkers.

Friend or Foe: A Systematic Review of Dupilumab and Alopecia Areata

[PMID:40378891 | Anagha Srivatsa et al. | Journal of the American Academy of Dermatology | 2025]

Reviews evidence that IL-4/IL-13 blockade with dupilumab has been associated with both improvement and development of alopecia areata in different patients.

Cause or Cure? Review of Dupilumab and Alopecia Areata

[PMID:31391150 | Dustin H. Marks, Natasha Mesinkovska, Maryanne M. Senna | Journal of the American Academy of Dermatology | 2023]

Examines contrasting reports of alopecia areata appearing or improving during dupilumab therapy and considers the role of Th2 immunity.

The Genetics of Alopecia Areata: What's New and How Will It Help Our Patients?

[PMID:21689242 | Lynn Petukhova et al. | PubMed-indexed Review | 2011]

Discusses early genome-wide association discoveries linking alopecia areata to immune-regulatory genes also implicated in other autoimmune disorders.

Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata

[PMID:32682334 | Multiple authors | Experimental Dermatology | 2020]

Reviews immune-suppressive mechanisms protecting growing follicles and explains how their disruption allows inflammatory lymphocytes to attack follicular tissue.

The Hair Follicle and Immune Privilege

[PMID:14582671 | Multiple authors | PubMed-indexed Review | 2003]

Presents foundational evidence that the growing hair bulb suppresses antigen presentation and creates a locally immunoinhibitory environment.

The Human Hair Follicle Immune System: Cellular Composition and Immune Privilege

[PMID:10809841 | Multiple authors | PubMed-indexed Research Article | 2000]

Maps immune cells around human follicles and demonstrates reduced major histocompatibility complex expression in protected proximal follicular regions.

Alopecia Areata — Targeted Treatments

Two Phase 3 Trials of Baricitinib for Alopecia Areata

[PMID:35334197 | Brett King et al. | New England Journal of Medicine | 2022]

Reports the BRAVE-AA1 and BRAVE-AA2 randomized trials in which oral baricitinib produced substantially greater scalp-hair regrowth than placebo in severe alopecia areata.

JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-analysis

[PMID:30762909 | K. Phan, D. F. Sebaratnam | Journal of the European Academy of Dermatology and Venereology | 2019]

Reviews early experience with tofacitinib, ruxolitinib, and baricitinib and documents substantial regrowth in many treated patients alongside frequent relapse after discontinuation.

The Efficacy and Safety of JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-analysis of Prospective Studies

[PMID:36091777 | Multiple authors | Frontiers in Pharmacology | 2022]

Pools prospective evidence for oral and topical JAK inhibition and finds stronger responses with systemic therapy.

The Evaluation of JAK Inhibitors on Effect and Safety in Alopecia Areata: A Systematic Review and Meta-analysis of 2,018 Patients

[PMID:37334349 | Mei-Qi Mao et al. | Frontiers in Immunology | 2023]

Combines randomized and observational studies to evaluate SALT-score improvement and adverse effects of multiple JAK inhibitors.

Safety of Oral JAK Inhibitors in Treating Alopecia Areata: A Systematic Review and Network Meta-analysis

[PMID:40860887 | Multiple authors | PubMed-indexed Network Meta-analysis | 2025]

Compares safety signals among oral JAK inhibitors, including acne, infection, lipid abnormalities, and creatine-phosphokinase elevation.

Comparative Efficacy and Safety of JAK Inhibitors in Moderate-to-Severe Alopecia Areata

[PMID:38659584 | Multiple authors | PubMed-indexed Network Meta-analysis | 2024]

Indirectly compares ritlecitinib, deuruxolitinib, brepocitinib, baricitinib, and other JAK-pathway treatments across clinical trials.

Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-analysis

[PMID:37368402 | Multiple authors | JAMA Network Open | 2023]

Finds that JAK inhibitors significantly improve SALT responses compared with placebo, with oral therapy demonstrating stronger evidence than topical treatment.

Comparative Efficacy and Safety of Systemic Steroids, Oral JAK Inhibitors and Contact Immunotherapy in Severe Alopecia Areata

[PMID:39042154 | Ruixuan Guan et al. | Archives of Dermatological Research | 2024]

Uses network meta-analysis to compare three major systemic or immune-directed treatment strategies for severe disease.

Hair Regrowth Outcomes of Contact Immunotherapy for Patients with Alopecia Areata: A Systematic Review and Meta-analysis

[PMID:30073292 | Multiple authors | JAMA Dermatology | 2018]

Pools more than 2,000 cases treated with DPCP or squaric acid dibutyl ester and evaluates regrowth, relapse, and prognostic factors.

Diphenylcyclopropenone in Patients with Alopecia Areata: A Critically Appraised Topic

[PMID:26511831 | R. A. Kuin et al. | British Journal of Dermatology | 2015]

Reviews evidence for DPCP contact immunotherapy in extensive and treatment-resistant alopecia areata and highlights major limitations in study quality.

Systematic Review and Quality Analysis of Studies on Topical Diphenylcyclopropenone Treatment for Alopecia Areata

[PMID:28619558 | Yong Hyun Jang et al. | Journal of the American Academy of Dermatology | 2017]

Evaluates the methodological quality and reported efficacy of DPCP studies and identifies the need for better controlled trials.

Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Alopecia Totalis or Universalis

[PMID:36884234 | Pascal Joly et al. | JAMA Dermatology | 2023]

Randomized trial evaluates methotrexate alone and in combination with prednisone for patients with severe alopecia totalis or universalis.

Hair Follicle Stem Cells, Aging, and Regeneration

Hair Follicle Stem Cells: Emerging Physiology and Therapeutic Applications

[PMID:42521973 | Shuyuan Yang et al. | Stem Cell Reviews and Reports | 2026]

Reviews hair-follicle stem-cell niches, regenerative functions, tissue repair, culture systems, biomaterial delivery, and future clinical applications.

Dysregulated Behaviour of Hair Follicle Stem Cells Triggers Alopecia and Provides Potential Therapeutic Targets

[PMID:35524394 | Yuanhong Liu et al. | Experimental Dermatology | 2022]

Examines how altered stem-cell activation, metabolism, aging, differentiation, and microenvironmental signaling can disrupt follicular regeneration.

An Updated Guide to Hair Follicle Stem Cell Markers and Changes in Their Expression with Aging

[PMID:41853462 | Theebah Sellathurai et al. | JID Innovations | 2026]

Reviews human and animal follicular stem-cell markers and describes how aging changes stem-cell populations and regenerative capacity.

Co-regulatory Mechanisms of Skin and Hair Aging

[PMID:42285235 | Hong Wu et al. | Experimental Gerontology | 2026]

Connects hair aging with DNA damage, telomere attrition, oxidative stress, inflammation, altered stem-cell niches, and systemic aging mechanisms.

Hair Follicle Stem Cells: Walking the Maze

[PMID:17576022 | Multiple authors | PubMed-indexed Review | 2007]

Reviews the diverse epithelial and mesenchymal stem-cell populations associated with follicles and the challenges of identifying reliable markers.

Hair Follicle Stem Cells

[PMID:17481931 | Multiple authors | Journal of Cell Science | 2007]

Reviews follicular stem-cell niches, developmental signaling pathways, gene-expression profiles, and cellular plasticity.

Advances in a Rapidly Emerging Field of Hair Follicle Stem Cell Research

[PMID:24851645 | Multiple authors | PubMed-indexed Review | 2014]

Describes advances in identifying follicular stem cells, understanding their fate, and exploring regenerative medicine and tissue-engineering applications.

Stem Cell-based Approaches for Alopecia: Current and Emerging Treatment Strategies

[PMID:42246281 | Pitsunan Paphawannasri et al. | Cell Transplantation | 2026]

Reviews hair-follicle stem cells, mesenchymal stem cells, induced pluripotent cells, and experimental regenerative approaches to hair restoration.

The Gut and Skin Microbiome in Alopecia: Associations and Interventions

[PMID:37915336 | Alexis E. Carrington et al. | Journal of Clinical and Aesthetic Dermatology | 2023]

Reviews emerging evidence connecting gut and scalp microbial communities with alopecia areata, androgenetic alopecia, CCCA, lichen planopilaris, and other disorders.

The Role of the Microbiome in Scalp Hair Follicle Biology and Disease

[PMID:30974503 | Multiple authors | Experimental Dermatology | 2019]

Examines interactions among follicular microorganisms, local immune responses, inflammation, hair cycling, and scalp disease.

Experimental Regenerative Treatments

Exosome-driven Treatments for Hair Regrowth in Androgenetic Alopecia

[PMID:42377704 | Sara Malih et al. | Molecular Biology Reports | 2026]

Systematically reviews preclinical and clinical research on extracellular vesicles intended to activate regenerative signaling and stimulate hair growth.

Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources

[PMID:40955427 | Multiple authors | PubMed-indexed Systematic Review | 2025]

Evaluates early clinical studies using exosomes derived from adipose tissue, placenta, follicles, bone marrow, umbilical cord, and other sources.

Exosomes as Regenerative Therapeutics in Non-scarring Alopecia: Current Perspectives and Future Directions

[PMID:41988106 | Multiple authors | Skin Appendage Disorders | 2026]

Reviews proposed mechanisms including WNT signaling, angiogenesis, immunomodulation, and prolongation of the anagen growth phase.

Progress in the Application of Exosomes in Androgenetic Alopecia: Focusing on Molecular Mechanisms

[PMID:42571418 | Yuanyuan Chen et al. | International Journal of Nanomedicine | 2026]

Examines how exosomal RNA, proteins, lipids, and signaling molecules may influence dermal papilla cells and follicular regeneration.

Exosome Therapy in Hair Regeneration: Evidence, Challenges, and Future Opportunities

[PMID:35441799 | Multiple authors | PubMed-indexed Review | 2022]

Reviews the early scientific evidence for exosome-based hair restoration while emphasizing the limited clinical validation and lack of standardized preparations.

Additional Androgenetic Alopecia Treatments

Efficacy and Safety of Fractional Laser Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis

[PMID:42121331 | Cheng Chen et al. | Journal of Cosmetic Dermatology | 2026]

Pools studies of ablative and non-ablative fractional laser therapy and reports improvements in hair density with generally manageable adverse effects.

Topical Minoxidil: Systematic Review and Meta-analysis of Its Efficacy in Androgenetic Alopecia

[PMID:26380504 | Aditya K. Gupta, Andrew Charrette | Skinmed | 2015]

Finds topical minoxidil superior to placebo for increasing total and nonvellus hair counts, while noting that cosmetically significant improvement occurs only in a subset of users.

The Efficacy and Safety of Oral Spironolactone in Female Pattern Hair Loss: A Systematic Review and Meta-analysis

[PMID:37719557 | Multiple authors | PubMed-indexed Systematic Review | 2023]

Reviews spironolactone as an antiandrogen treatment for female-pattern hair loss and evaluates improvement rates, combination therapy, and adverse effects.

The Efficacy and Use of Finasteride in Women: A Systematic Review

[PMID:30604525 | Allison C. Hu, Lance W. Chapman, Natasha A. Mesinkovska | International Journal of Dermatology | 2019]

Reviews finasteride use in women with female-pattern hair loss, hyperandrogenic disorders, frontal fibrosing alopecia, and other conditions while identifying major gaps in randomized evidence.